Screener
Kailera Therapeutics KLRA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kailera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Kailera Therapeutics’s 10-Q, filed May 26, 2026.
- Filed
- May 26, 2026, 4:29 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-239417
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $111,826 | $160,267 |
| Marketable securities | 407,348 | 385,789 |
| Prepaid expenses and other current assets | 11,141 | 11,481 |
| Total current assets | 530,315 | 557,537 |
| Property and equipment, net | 1,854 | 1,955 |
| Restricted cash | 761 | 761 |
| Long-term marketable securities | 62,747 | 106,672 |
| Non-current clinical deposits | 13,318 | 12,185 |
Item 1. Financial Statements.
FAQ
- What is Kailera Therapeutics's total current assets?
- Kailera Therapeutics (KLRA) reported total current assets of $530.32M in Q1 2026.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Kailera Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude